Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b

NCT06934824 is registered in ClinicalTrials.gov with Hebei Medical University as lead sponsor.

NCT NCT06934824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06934824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b
Lead sponsor
Hebei Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
January 1, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer patients undergoing minimally invasive gastrectomy